DrugPatentWatch Database Preview
DEPO-SUBQ PROVERA 104 Drug Profile
» See Plans and Pricing
Which patents cover Depo-subq Provera 104, and what generic alternatives are available?
Depo-subq Provera 104 is a drug marketed by Pharmacia And Upjohn and is included in one NDA. There is one patent protecting this drug.
This drug has forty-three patent family members in twenty-nine countries.
The generic ingredient in DEPO-SUBQ PROVERA 104 is medroxyprogesterone acetate. There are twenty drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the medroxyprogesterone acetate profile page.
US ANDA Litigation and Generic Entry Outlook for Depo-subq Provera 104
A generic version of DEPO-SUBQ PROVERA 104 was approved as medroxyprogesterone acetate by BARR on August 9th, 1996.
Summary for DEPO-SUBQ PROVERA 104
| International Patents: | 43 |
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 71 |
| Clinical Trials: | 52 |
| Patent Applications: | 3,934 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | DEPO-SUBQ PROVERA 104 at DailyMed |
Recent Clinical Trials for DEPO-SUBQ PROVERA 104
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Teva Branded Pharmaceutical Products R&D, Inc. | Phase 1 |
| MU-JHU CARE | Phase 4 |
| University of California, San Diego | Early Phase 1 |
Pharmacology for DEPO-SUBQ PROVERA 104
| Drug Class | Progestin |
US Patents and Regulatory Information for DEPO-SUBQ PROVERA 104
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacia And Upjohn | DEPO-SUBQ PROVERA 104 | medroxyprogesterone acetate | INJECTABLE;SUBCUTANEOUS | 021583-001 | Dec 17, 2004 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for DEPO-SUBQ PROVERA 104
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Pharmacia And Upjohn | DEPO-SUBQ PROVERA 104 | medroxyprogesterone acetate | INJECTABLE;SUBCUTANEOUS | 021583-001 | Dec 17, 2004 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for DEPO-SUBQ PROVERA 104
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| New Zealand | 522324 | Start Trial |
| World Intellectual Property Organization (WIPO) | 0187266 | Start Trial |
| Denmark | 1282402 | Start Trial |
| Czech Republic | 303872 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for DEPO-SUBQ PROVERA 104
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0113964 | 97C0037 | Belgium | Start Trial | PRODUCT NAME: OESTROGENES EQUINS CONJUGUES; ACETATE DE MEDROXYPROGESTERONE; NAT. REGISTRATION NO/DATE: NL 19569 19950301; FIRST REGISTRATION: CH - 52647 01 010 19940826 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
